School of Medicine
Showing 1-100 of 289 Results
-
Kari Nadeau, MD, PhD
Naddisy Foundation Professor of Pediatric Food Allergy, Immunology and Asthma, Professor of Pediatrics, Senior Fellow at the Woods Institute and Professor, by courtesy, of Otolaryngology and of Epidemiology and Population Health at LPCH
Current Research and Scholarly Interests Kari Nadeau, MD, PhD, Allergy, Immunology and Asthma
Our research interests in the laboratory focus on the role of human T cells, specifically natural regulatory T cells (Treg, in immunological diseases. We aim to differentiate the mechanisms of action of regulatory T cell suppressive function. We study how pollution, such as diesel exhause, disrupt Treg suppressive function and how chemokines, like lymphotactin, enhance Treg suppressive function. We also study Treg function in tolerance. -
Helen Nadel
Clinical Professor, Radiology - Pediatric Radiology
Current Research and Scholarly Interests Clinical research and scholarly interests include topics in Pediatric Nuclear Medicine to include AI evaluation for scintigraphic quantitation, PET MR evaluation of optimized techniques for use in pediatric patient managment
-
Claude M. Nagamine, DVM, PhD
Associate Professor of Comparative Medicine at the Stanford University Medical Center
Current Research and Scholarly Interests Mouse models to study murine and human infectious diseases. These colloborative studies include dengue virus, zika virus, adeno-associated virus, coxsackie virus, enterovirus 71, enterohepatic helicobacters, campylobacters, and anaplasma.
-
Seema Nagpal, MD
Clinical Associate Professor, Neurology & Neurological Sciences
Current Research and Scholarly Interests I'm a board certified neuro-oncologist who treats both primary brain tumors as well as metastatic disease to the brain and nervous system. My research concentrates on clinical trials for patients with late-stage central nervous system cancer. I have a special interest in leptomeningeal disease, a devastating complication of lung and breast cancers. I collaborate with Stanford scientists to detect this disease earlier, and with our breast and lung oncologists to improve outcomes for patients.
-
Ramesh Nair
Director of Bioinformatics, SCGPM, Genetics
Current Role at Stanford Director, Bioinformatics
Stanford Center for Genomics and Personalized Medicine (SCGPM)
Center of Excellence in Stem Cell Genomics (CESCG)
Stanford University School of Medicine -
Michitaka Nakano
Postdoctoral Research Fellow, Hematology
Current Research and Scholarly Interests Understanding of tumor biology using cancer organoid from the clinical view point.
-
Hiromitsu (Hiro) Nakauchi
Professor of Genetics (Stem Cell)
Current Research and Scholarly Interests Translation of discoveries in basic research into practical medical applications
-
Yusuke Nakauchi
Instructor, Stanford Cancer Institute
Current Research and Scholarly Interests From 2005 to 2010, my work as a clinical hematology fellow allowed me to experience first-hand how scientific advances that started in a laboratory can transform the lives of patients. While many of my patients were cured of their disease with allogeneic hematopoietic stem cell transplantation, underscoring the importance of anti-tumor immunotherapy in eradicating leukemia, I witnessed face-to-face their suffering from the long-term consequence of graft-versus-host disease (GVHD). This experience was ultimately what drove me to engage in research to discover novel therapies. For this reason, I embarked on a PhD program in 2010 to design antibody therapy to (i) target GVHD and (ii) target hematological malignancies. Under the mentorship of Professor Hiromitsu Nakauchi at the University of Tokyo, an international leader in hematopoiesis, I developed allele-specific anti-human leukocyte antigen (HLA) monoclonal antibodies for severe GVHD caused by HLA-mismatched hematopoietic stem cell transplantation (Nakauchi et al., Exp Hematol, 2015). This study was the first to find that anti-HLA antibodies can be used therapeutically against GVHD. That success gave me the motivation and confidence to further my research beyond targeting GVHD, to targeting leukemic stem cells through my current postdoctoral fellowship in the laboratory of Professor Ravindra Majeti, Department of Hematology at Stanford University.
Many people suffer from leukemia each year, but we still don?t know how to completely cure it. Recent advances in sequencing technologies have tremendously improved our understanding of the underlying mutations that drive hematologic malignancies, although, the reality is that the majority of the mutations are not easily ?druggable? and the discovery of these mutations has not yet made a significant impact in patient outcomes. I view this perhaps the most crucial challenges facing a translational cancer researcher like myself. My current research is a major step toward my long term goal to make personalized medicine a reality for patients with acute myeloid leukemia (AML) and other hematologic malignancies. Although my research is focused on targeting Ten-Eleven Translocation methylcytosine dioxygenase-2 (TET2) mutations, I anticipate it will lead to a better understanding of the cell context requirement for TET2 mutations in AML and help identify the critical cells to target to both prevent the development of de novo leukemia and halt relapse. It may also prove of value to understanding of the biology of a range of other cancers. -
Shweta S. Namjoshi MD MPH CNSC
Clinical Assistant Professor, Pediatrics - Gastroenterology
Bio Dr. Namjoshi specializes in the care and support of children with intestinal failure on home parenteral nutrition (PN). Her research interests include long term outcomes for patients on home PN, iron in gastrointestinal diseases, renal and bone health in intestinal failure, clinical pathologic correlates in intestinal failure, and the assessment of congenital enteropathies.
-
Sandy Napel
Professor of Radiology (Integrative Biomedical Imaging Informatics) and, by courtesy, of Medicine (Medical Informatics) and of Electrical Engineering
Current Research and Scholarly Interests My research seeks to advance the clinical and basic sciences in radiology, while improving our understanding of biology and the manifestations of disease, by pioneering methods in the information sciences that integrate imaging, clinical and molecular data. A current focus is on content-based radiological image retrieval and integration of imaging features with clinical and molecular data for diagnostic, prognostic, and therapy planning decision support.
-
Diana Naranjo
Clinical Professor, Pediatrics - Endocrinology and Diabetes
Bio As a licensed clinical psychologist working in diabetes and Cystic Fibrosis clinics for the past 10 years, Dr. Naranjo focuses on the psychosocial needs of patients and families with diabetes and CF. Through clinical research, she aims to understand barriers and facilitators to diabetes self-management, how families and individuals with diabetes respond to health technology, and how to best provide services that engage youth and their families. She is a member of the Stanford Diabetes Research Center.
-
Manjari Narayan
Postdoctoral Research Fellow, Developmental Behavioral Pediatrics
Bio Manjari Narayan is a postdoctoral research scholar in the School of Medicine. Her current research interests combine high dimensional statistics, network science & statistical causal inference methods to analyze changes in brain networks either longitudinally or due to experimental perturbations. She received a Ph.D in Electrical Engineering from Rice University in 2016 under the supervision of Dr. Genevera Allen and a B.S in Electrical Engineering from UIUC in 2007. Previously, she was a postdoctoral scholar in Psychiatry under the mentorship of Amit Etkin. Her dissertation work has been recognized by numerous student paper awards including the 2016 ENAR Distinguished Student Paper Award from the International Biometrics Society and the 2013 best paper travel award in Pattern Recognition in Neuroimaging.
-
Raja Narayan, MD MPH
Affiliate, Dean's Office Operations - Dean Other
Bio A Bay Area native, Dr. Raja Narayan attended James Logan High School in Union City before going on to Berkeley to obtain his BS in Chemical Biology. He earned his MPH in Biostatistics from Yale before his MD at the University of California, Irvine. Dr. Narayan joined the Stanford General Surgery residency program in 2015.
Prior to joining Stanford, Dr. Narayan collaborated with the online education platform, Khan Academy, where he developed a library of Physiology videos for the MCAT as well as clinical videos for the NCLEX. While at Yale, Dr. Narayan led a multi-disciplinary team of engineers, pathologists, and surgeons to design, construct, test, and patent a device that preserves intestinal tissue better than the standard of care used to preserve harvested tissue for small bowel transplantation. This work earned him grants from the Yale Center for Engineering, Innovation, and Design as well as the Excellence in Medicine and Physician of Tomorrow awards by the American Medical Association.
Between 2017-2019, Dr. Narayan spent a research sabbatical with the Hepatopancreatobiliary Surgery service at the Memorial Sloan Kettering Cancer Center studying targets for pancreatic cancer vaccines, genomic correlates of liver tumor biology, and regional differences in biliary tree cancer arising in patients from around the world. Since returning to Stanford in June 2019, Dr. Narayan now leads a team studying the use of artificial intelligence to define donor liver histopathology to predict the risk for early graft failure after transplantation.
After completion of his residency training, Dr. Narayan plans to pursue a fellowship in Complex General Surgical Oncology. -
Sanjiv Narayan
Professor of Medicine (Cardiovascular Medicine) at the Stanford University Medical Center
Current Research and Scholarly Interests Dr. Narayan directs the Computational Arrhythmia Research Laboratory, whose goal is to define the mechanisms underlying complex human heart rhythm disorders, to develop bioengineering-focused solutions to improve therapy that will be tested in clinical trials. The laboratory has been funded continuously since 2001 by the National Institutes of Health, AHA and ACC, and interlinks a disease-focused group of clinicians, computational physicists, bioengineers and trialists.
-
Zui Narita
Postdoctoral Research Fellow, Psychiatry
Bio Zui (???) is a Board Certified Psychiatrist of Japan, who is interested in two major research topics. First, Zui is eager to understand how brain stimulation techniques (e.g., TMS, DBS, and tDCS) might improve the functions and symptoms in psychiatric disorders. Second, Zui wishes to know how biological outcomes such as brain images may predict the onset and severity of mental disorders, in the context of biomarkers for these conditions. Thus, his postgraduate training has laid the foundation for these goals. During his time in Japan, Zui conducted clinical trials that examined the effect of tDCS in patients with schizophrenia. In these trials, he found that the neural activity as measured by NIRS at baseline predicts the treatment effect of tDCS in this condition. After coming to the US, he learned advanced statistical methods in the Johns Hopkins Bloomberg School of Public Health. Zui joined the Brain Stimulation Lab in 2020 and is currently engaged in clinical trials for depression/OCD/bipolar disorder.
-
Anupama Narla
Assistant Professor of Pediatrics (Hematology/Oncology) at the Lucile Salter Packard Children's Hospital
Current Research and Scholarly Interests My research interests are to study the pathophysiology of ribosomopathies and to translate these insights into the work-up and management of pediatric bone marrow failure syndromes.
-
Aussama Nassar, MD, MSc,FACS, FRCSC
Clinical Assistant Professor, Surgery - General Surgery
Bio Dr. Nassar is a board certified General Surgeon in both the USA and Canada. Dr. Nassar has five years of clinical experience in tertiary care referral academic health-centres in Canada prior to joining Stanford University in surgery, trauma and critical care. His clinical interests are emergency and elective surgery in addition to trauma and critical care medicine. He is also a skilled endoscopist performing both upper and lower gastrointestinal endoscopy. His research interests are varied and include the development of assessment tools for trainees, burnout among physicians and other healthcare professionals. In addition he is especially interested in training trainees in simulation based medical education with a focus on perioperative inter-professional collaboration and patient safety. He is a true clinician educator and is a certified simulation educator as well as an ATLS course director. Dr. Nassar has also earned an MSc degree in Health Science Education from McMaster University, Canada.
-
Arutselvan Natarajan
Sr Res Scientist _ Life Science, Rad/Molecular Imaging Program at Stanford
Current Role at Stanford Senior Scientist
-
Kalpana Isabel Nathan
Clinical Associate Professor (Affiliated) [Vapahcs], Psychiatry VA Research
Bio Kalpana Nathan, MD is an attending psychiatrist at the VA Palo Alto Health Care System and a clinical associate professor (affiliated) of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine. After completion of residency and research fellowship at Stanford, she served 4 years at the San Francisco General Hospital/UCSF, gaining experience in the areas of substance use, HIV and public health. She has worked and taught in various settings, both inpatient and outpatient, as well as private and public sectors. She is board certified in General, Addiction and Forensic Psychiatry. Her interests include wellness and self-care for physicians, philosophy and human rights education. She is a certified meditation teacher, has completed sprint and Olympic triathlons, and enjoys traveling around the world. She received the outstanding community clerkship preceptor award in 2010 and the Arthur L. Bloomfield Award in Recognition of Excellence in the Teaching of Clinical Medicine in 2015 at the Stanford University School of Medicine.
Recent Publications:
1. Nathan N & Nathan KI: Suicide, Stigma, and Utilizing Social Media Platforms to Gauge Public Perceptions. Front. Psychiatry 2020 January 13
2. Tran BX, Nathan KI, Phan HT, Hall BJ, Vu GT et al: A Global Bibliometric Analysis of Services for Children Affected by HIV/Acquired Immune Deficiency Syndrome: Implications for Impact Mitigation Programs (GAPRESEARCH). AIDS Rev. 2019 Oct 3;21(3).
3.Lee A, Nathan KI: Understanding Psychosis in a Veteran With a History of Combat and Multiple Sclerosis. Fed Pract. 2019 Jun;36(Suppl 4):S32-S35.
4. Tran BX, Ha GH, Vu GT, Nguyen LH, Latkin CA, Nathan K, McIntyre RS, Ho CS, Tam WW, Ho RC: Indices of Change, Expectations, and Popularity of Biological Treatments for Major Depressive Disorder between 1988 and 2017: A Scientometric Analysis. Int J Environ Res Public Health. 2019 Jun 26;16(13) -
Yasodha Natkunam, M.D., Ph.D
Ronald F. Dorfman, MBBch, FRCPath Professor in Hematopathology
Current Research and Scholarly Interests My research interests focus on the identification and characterization of markers of diagnostic and prognostic importance in hematolymphoid neoplasia.
-
Jayakar V. Nayak, MD, PhD
Associate Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Neurosurgery at the Stanford University Medical Center
Current Research and Scholarly Interests Upper Airway Stem Cell Biology, Fate, and Repair/Regeneration of the Airway Epithelium to treat Upper and Lower Airway Disorders
-
Rosamond Naylor
William Wrigley Professor, Senior Fellow at the Woods Institute for the Environment and at the Freeman Spogli Institute for International Studies and Professor, by courtesy, of Economics
Current Research and Scholarly Interests Research Activities:
My research focuses on the environmental and equity dimensions of intensive food production systems, and the food security dimensions of low-input systems. I have been involved in a number of field-level research projects around the world and have published widely on issues related to climate impacts on agriculture, distributed irrigation systems for diversified cropping, nutrient use and loss in agriculture, biotechnology, aquaculture and livestock production, biofuels development, food price volatility, and food policy analysis.
Teaching Activities:
I teach courses on the world food economy, food and security, aquaculture science and policy, human society and environmental change, and food-water-health linkages. These courses are offered to graduate and undergraduate students through the departments of Earth System Science, Economics, History, and International Relations.
Professional Activities:
William Wrigley Professor of Earth Science (2015 - Present); Professor in Earth System Science (2009-present); Director, Stanford Center on Food Security and the Environment (2005-2018); Associate Professor of Economics by courtesy (2000-present); William Wrigley Senior Fellow, Freeman Spogli Institute for International Studies and the Woods Institute for the Environment (2007-2015); Trustee, The Nature Conservancy CA program (2012-present); Member of the Scientific Advisory Board for the Beijer Institute for Ecological Economics in Stockholm (2011-present), for the Aspen Global Change Institute (2011-present), and for the Aldo Leopold Leadership Program (2012-present); Aldo Leopold Leadership Fellow in Environmental Science and Public Policy (1999); Pew Fellow in Conservation and the Environment (1994). Associate Editor for the Journal on Food Security (2012-present). Editorial board member for Aquaculture-Environment Interactions (2009-present) and Global Food Security (2012-present). -
Rahim Nazerali
Clinical Assistant Professor, Surgery - Plastic & Reconstructive Surgery
Bio Rahim Nazerali, MD, MHS, is a Clinical Assistant Professor of Surgery in the Division of Plastic and Reconstructive Surgery at Stanford Heath Care. Dr. Nazerali specializes in both reconstructive and aesthetic surgery, including face and body rejuvenation, breast augmentation and reconstruction, abdominal wall reconstruction for hernia defects, body contouring, complex wound management and tissue transfer.
Prior to joining Stanford, Dr. Nazerali trained at the University of California, Davis Medical Center in a combined residency in General Surgery and Plastic Surgery, receiving extensive experience in both cosmetic and post-trauma reconstruction. He then completed his fellowship training at Stanford Hospital in microsurgery and complex reconstruction. Dr. Nazerali also holds a Master?s of Health Science in Public Health from the Johns Hopkins Medical Institute.
As a plastic surgeon, Dr. Nazerali specializes in the treatment of patients requiring skilled plastic and reconstructive surgery after cancer treatments. Dr. Nazerali focuses on providing advanced surgical restoration of form and function, with expertise in the reconnection of nerves, muscles, and blood vessels.
His clinical focus includes Abdominal Wall Reconstruction, Breast Reconstruction including DIEP flap reconstruction, Aesthetic and Cosmetic Surgery, Microsurgery, and Reconstructive Surgery.
On a personal level, Dr. Nazerali strongly believes in contributing to the lives of the community in which he lives. Since his youth, he has volunteered countless hours towards helping the sick, elderly, and disabled. He travels extensively and has provided reconstructive surgical services to adults and children in multiple areas of the world. -
Joel Neal, MD, PhD
Associate Professor of Medicine (Oncology) at the Stanford University Medical Center
Current Research and Scholarly Interests I am a thoracic oncologist who cares for patients with non-small cell lung cancer, malignant mesothelioma, and other thoracic malignancies. I design and conduct clinical trials of novel therapies in collaboration with other researchers and pharmaceutical companies. These generally focus on two areas, 1) targeted therapies against particular mutations in cancers (for example EGFR, ALK, ROS1, HER2, KRAS, MET, and others) and 2) the emerging field of immunotherapy in cancer, using anti PD-1/PD-L1 therapies in combination with other agents, and also developing cellular therapies. I also collaborate with other researchers on campus to apply emerging technologies to cancer therapy, for example, circulating tumor DNA detection. Additionally, in my role as the Cancer Center IT Medical Director, I coordinate projects relating to our use of the electronic health record to improve provider efficiency and facilitate patient care.
